Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3267
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03839693 | ET-01 in Subjects With Lateral Canthal Lines, LCL-208 | ||
| NCT05096221 | A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) | ||
| NCT02228525 | Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes | ||
| NCT07034768 | A Study to Evaluate EDG-7500 in People With Renal Impairment | ||
| NCT05783089 | MSLN-targeted CAR-T Cells in Solid Tumors. | ||
| NCT05621252 | Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809) | ||
| NCT05676749 | C-TIL051 in Non-Small Cell Lung Cancer | ||
| NCT07026916 | A Phase II Study to Evaluate GFH375 in Patients With KRAS G12D Mutant Metastatic Pancreatic Cancer | ||
| NCT06633016 | Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY) | ||
| NCT03166085 | PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer | ||
| NCT02249091 | A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) | ||
| NCT01350128 | PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | ||
| NCT06736704 | SNV4818 in Participants With Advanced Solid Tumors | ||
| NCT02790632 | Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage | ||
| NCT05947955 | Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS) | ||
| NCT06598371 | A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors | ||
| NCT00538863 | Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain | ||
| NCT03271021 | A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris | ||
| NCT04007536 | A Study of Potential Treatment-Responsive Biomarkers and Clinical Outcomes in Hunter Syndrome | ||
| NCT03229798 | Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002) | ||
| NCT03458416 | A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome | ||
| NCT01750684 | AC105 in Patients With Acute Traumatic Spinal Cord Injury | ||
| NCT03936699 | ELIRA 2: Safety and Effectiveness of TENS Assisted Weight Loss and Appetite Suppression | ||
| NCT04843787 | SLV213 Treatment in Ambulatory COVID-19 Patients | ||
| NCT03326921 | HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant | ||
| NCT07198321 | A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors | ||
| NCT05450549 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL919 in Healthy Participants | ||
| NCT06249048 | Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab | ||
| NCT04846530 | Teosyal RHA® Histology and Intradermal Implantation Evaluation Study | ||
| NCT05578092 | A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway | ||
| NCT04072432 | A Study of RBT-3 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease | ||
| NCT06659549 | A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD | ||
| NCT05484011 | A Maintenance Therapy Study of Odetiglucan With CDX-1140 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma | ||
| NCT05276063 | A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) | ||
| NCT03546816 | Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis | ||
| NCT02716246 | Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH | ||
| NCT03466073 | A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP | ||
| NCT00324129 | A Phase I Study of MGCD0103 Given Three-Times Weekly In Patients With Leukemia Or Myelodysplastic Syndromes | ||
| NCT00736372 | A Trial of PX-12 in Patients With a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic Cancer | ||
| NCT03385239 | Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD) | ||
| NCT07115745 | A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases | ||
| NCT03858972 | Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC | ||
| NCT00381303 | GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men. | ||
| NCT00777231 | Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies | ||
| NCT04205227 | ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors | ||
| NCT03085173 | A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies | ||
| NCT03911102 | Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines | ||
| NCT06628362 | A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus | ||
| NCT00889642 | Safety and Efficacy Study of an Iontophoretic Patch Containing Lidocaine and Epinephrine for Venipuncture in Healthy Adult Volunteers | ||
| NCT02275351 | A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA) |
